Evidence map›Paper›PMID 29984523›Full record

ArticleJournal of medical virology2018

Epidemiology of rubella infection and genotyping of rubella virus in Cote d'Ivoire, 2012-2016.

Herve A Kadjo, Diane Waku-Kouomou, Marius Adagba, Emily S Abernathy, Ouattara Abdoulaye, Edgard Adjogoua, Fanta Coulibaly-Traore, Sylla Aboubacar, Ekra Daniel, Joseph Icenogle and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of medical virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Herve A KadjoDepartment of Epidemic Viruses, Pasteur Institute of Cote d'Ivoire, Abidjan, Cote d'Ivoire.ORCID 0000-0002-5072-1805
Diane Waku-KouomouIHRC Inc, Contracting Agency to the Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, United States Centers for Disease Control and Prevention, Atlanta, Georgia.
Marius AdagbaDepartment of Epidemic Viruses, Pasteur Institute of Cote d'Ivoire, Abidjan, Cote d'Ivoire.
Emily S AbernathyDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, United States Centers for Disease Control and Prevention, Atlanta, Georgia.
Ouattara AbdoulayeDepartment of Epidemic Viruses, Pasteur Institute of Cote d'Ivoire, Abidjan, Cote d'Ivoire.
Edgard AdjogouaDepartment of Epidemic Viruses, Pasteur Institute of Cote d'Ivoire, Abidjan, Cote d'Ivoire.
Fanta Coulibaly-TraoreDepartment of Epidemic Viruses, Pasteur Institute of Cote d'Ivoire, Abidjan, Cote d'Ivoire.
Sylla AboubacarDepartment of Epidemic Viruses, Pasteur Institute of Cote d'Ivoire, Abidjan, Cote d'Ivoire.
Ekra DanielDirection du Programme Elargi de Vaccination (Ministere de la Sante).
Joseph IcenogleDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, United States Centers for Disease Control and Prevention, Atlanta, Georgia.
Mireille DossoDepartment of Epidemic Viruses, Pasteur Institute of Cote d'Ivoire, Abidjan, Cote d'Ivoire.
Institut Pasteur · FRCenters for Disease Control and Prevention · US

Funding

Intramural CDC HHS CC999999Ministry of Health of Cote D'IvoireU.S. Centers for Diseases Control and PreventionWorld Health Organization AFRO (WHO-AFRO)
6 · The paper itself

Abstract

Rubella is a contagious disease caused by the rubella virus (RuV) that can lead to serious birth defects when women are infected in early pregnancy. This study aimed to describe the epidemiology and genetic diversity of rubella viruses in Cote d'Ivoire (CIV). Blood or oral fluid samples collected from suspected measles cases were first tested for the presence of measles specific IgM antibodies by enzyme-linked immunosorbent assay (ELISA). All measles IgM negative or indeterminate samples were tested for rubella IgM antibody using ELISA. Rubella-IgM-positive samples were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) for the presence of rubella virus RNA. Real-time RT-PCR-positive RNA samples were used as template to amplify the 739 nt region used for rubella genotyping. PCR-positive samples were sequenced and phylogenetic analysis performed. Between 2012 and 2016, 4121 serums and 126 oral fluids were collected through the measles surveillance system. Of these, 3823 and 108 respectively were measles IgM negative or indeterminate. Subsequent testing for rubella found that 690 of 3823 (18%) serum samples and 25 of 108 (23%) oral fluid samples were rubella IgM-positive. The 739 nt segment of the E1 glycoprotein gene was amplified and sequenced for two serums and seven oral fluids samples. Phylogenetic analysis showed that the rubella viruses from CIV belonged to genotypes 1G (eight samples) and 2B (one sample). Rubella virus genotype 2B was found in CIV for the first time. These data contribute to baseline information on rubella virus strains found in CIV before the introduction of rubella vaccine.

Indexed as

GenotypeAdolescentAdultAgedAged, 80 and overAntibodies, ViralBloodChildChild, PreschoolCote d'IvoireEnzyme-Linked Immunosorbent AssayFemaleGenotyping TechniquesHumansImmunoglobulin MInfantAntibodies, ViralImmunoglobulin MAfricaCote d’Ivoireepidemiologygenotypingrubella infection

Identifiers

PMID29984523
PMCPMC9169462
OpenAlexW2862377908

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.